Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Feb;13(2):209–212. doi: 10.1111/j.1365-2125.1982.tb01358.x

Antihypertensive action of acebutolol (Sectral) when used concomitantly with hydrochlorothiazide.

P A Mitenko, J K McKenzie, J J Brossard
PMCID: PMC1401992  PMID: 7059418

Abstract

1 In a placebo-controlled study, the respective anti-hypertensive effects of hydrochlorothiazide and hydrochlorothiazide plus the beta-adrenoceptor blocker acebutolol were assessed in 18 patients with moderately severe essential hypertension. 2 Hydrochlorothiazide 100 mg daily decreased the mean supine blood pressures from 163/107 mmHg to 150/103 mmHg. Addition of acebutolol in a single-blind fashion in doses up to 800 mg daily reduced mean supine pressure to 137/95 mmHg. Further increases in acebutolol dosage to a maximum of 2000 mg daily in 13 patients whose hypertension was not well controlled on lower doses resulted in a mean supine blood pressure of 132/92 mmHg.

Full text

PDF
209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benson M. K., Berrill W. T., Cruickshank J. M., Sterling G. S. A comparison of four beta-adrenoceptor antagonists in patients with asthma. Br J Clin Pharmacol. 1978 May;5(5):415–419. doi: 10.1111/j.1365-2125.1978.tb01647.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hansson L., Berglund G., Andersson O., Holm M. Controlled trial of acebutolol in hypertension. Eur J Clin Pharmacol. 1977 Oct 14;12(2):89–92. doi: 10.1007/BF00645127. [DOI] [PubMed] [Google Scholar]
  3. Harms H. H., Spoelstra A. J. Cardiac and bronchial beta-adrenoceptor antagonistic potencies of atenolol, metoprolol, acebutolol, practolol, propranolol and pindolol in the anaesthetized dog. Clin Exp Pharmacol Physiol. 1978 Jan-Feb;5(1):53–59. doi: 10.1111/j.1440-1681.1978.tb00651.x. [DOI] [PubMed] [Google Scholar]
  4. Letac B., Fillastre J. P., Wolf L. M., Safar M. Le traitement de l'hypertension artérielle par l'acébutolol. Etude en double aveugle contre placebo. Nouv Presse Med. 1975 Dec 31;4(46 Suppl):3273–3277. [PubMed] [Google Scholar]
  5. Martin M. A., Phillips C. A., Smith A. J. Acebutolol in hypertension--double-blind trial against placebo. Br J Clin Pharmacol. 1978 Oct;6(4):351–356. doi: 10.1111/j.1365-2125.1978.tb00863.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Martin M. A., Phillips F. C., Tucker G. T., Smith A. J. Acebutolol in hypertension: relationships between drug concentration and effects. Eur J Clin Pharmacol. 1978 Dec 18;14(6):383–390. doi: 10.1007/BF00716378. [DOI] [PubMed] [Google Scholar]
  7. Turner P. Beta adrenoceptor blocking drugs in hypertension. Clin Invest Med. 1978;1(3-4):129–133. [PubMed] [Google Scholar]
  8. Winkle R. A., Meffin P. J., Ricks W. B., Harrison D. C. Acebutolol metabolite plasma concentration during chronic oral therapy. Br J Clin Pharmacol. 1977 Oct;4(5):519–522. doi: 10.1111/j.1365-2125.1977.tb00779.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES